Instituto Médico DAMIC

Recent papers from Instituto Médico DAMIC

1. Reduction in total cardiovascular events with evolocumab in patients with no prior myocardial infarction or stroke: a pre-specified analysis of VESALIUS-CVEuropean Heart Journal · 2026
2. Delivery of cardiac rehabilitation through hybrid models and alternative settings by country income classification and decade: Comparisons from the International Council of Cardiovascular Prevention and Rehabilitation’s 2025 Global Audit UpdatePLoS ONE · 2026
3. Cardiac rehabilitation coverage and program characteristics in Latin America and the Caribbean: Comparisons from the ICCPR’s 2025 Global Audit UpdateBrazilian Journal of Physical Therapy · 2026
4. Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart FailureJournal of the American College of Cardiology · 2005
5. A Polypill Strategy to Improve AdherenceJournal of the American College of Cardiology · 2014
6. Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trialEuropean Heart Journal · 2026
7. Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV StudyJournal of the American College of Cardiology · 2026
8. Contemporary non-statin therapies for dyslipidemia management: achieving current lipid targetsFrontiers in Medicine · 2026
9. Cardiac rehabilitation referral and access by country income class: Comparisons from the International Council of Cardiovascular Prevention and Rehabilitation’s 2025 Global Audit UpdateEuropean Journal of Internal Medicine · 2026
10. Staffing, Accepted Indications and Dose of Phase II Cardiac Rehabilitation: Country Income Class and Time-Based Comparisons from the International Council of Cardiovascular Prevention and Rehabilitation’s (ICCPR) 2025 Audit UpdateEuropean Journal of Preventive Cardiology · 2026
11. Early Versus Late Initiation of Evolocumab and Arterial Aneurysm Events: An Analysis of FOURIER and FOURIER-OLECirculation · 2026
12. Evolocumab in Patients without a Previous Myocardial Infarction or StrokeNew England Journal of Medicine · 2025
13. ANGPTL3 Gene Editing: Promise and PrudenceEuropean Cardiology Review · 2026
14. Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 DiabetesJAMA Cardiology · 2026
15. Self‐Administered Etripamil Nasal Spray Slows Ventricular Rate in Patients With Atrial Fibrillation: A Post Hoc Analysis of the NODE‐303 StudyJournal of Cardiovascular Electrophysiology · 2026
16. Interventions to improve adherence to lipid-lowering drugs: a systematic review and meta-analysisEClinicalMedicine · 2025
17. HPV and co-infections: impacts on semen inflammation, oxidative stress, and sperm qualityFrontiers in Cellular and Infection Microbiology · 2025
18. Cardio-Obstetrics Practice in Latin AmericaJACC Advances · 2024
19. Sperm quality, oxidative stress and semen inflammation in HPV male urogenital infection: the role of co-infections.2024
20. Impact of high-risk and low-risk human papillomavirus infections on the male genital tract: effects on semen inflammation and sperm qualityFrontiers in Cellular and Infection Microbiology · 2024